단일기관에서 혈액투석 환자의 반코마이신 치료적 약물 농도 모니터링 업무 운영 실태 조사와 업무 개선 방안
An Improvement Plan with for the Assessment of Therapeutic Drug Monitoring Services for Vancomycin in Hemodialysis Patients: A Single Institution
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Vancomycin is a commonly administered antibiotic for hemodialysis patients. However, the best dosing and monitoring algorithms for these patients remain unclear thus far. The purpose of this study is to analyze and improve therapeutic drug monitoring (TDM) services for vancomycin in hemodialysis patients. Methods : Hemodialysis patients with TDM services between January 2015 and June 2016 were included. Sixty four cases of TDM services in 30 patients were retrospectively reviewed. Results : Appropriacy Among the 61(95%) reports recommending serum sampling time, 33(52%) cases followed the recommended sampling time for both peak and trough concentration. There were 12 errors across the 10 reports; all of them were a result of poor awareness of the administration of vancomycin. When additional TDM was followed, the time taken to the 2nd TDM (follow-up TDM) was between 4 and 30 days. Efficiency A total of 37(58%) cases followed the recommended dosing regimen and the total that did not follow were 20(31%). In the remaining cases(7 cases, 11%), the vancomycin administration was ceased after prior TDM. Among the 37(58%) cases, following the recommended dosing regimen, 9(24%) reports were expected to achieve the target trough level. Among the 20(31%) cases that did not follow the recommended dosing regimens, none of the reports achieved the target trough level. Conclusion : In our institutions’TDM services, TDM reports’appropriacy is unsatisfactory because the sampling wasn’t taken at the recommended times. The awareness of the vancomycin administration was poor and the 2nd TDM was delayed. Also, the TDM reports’efficiency were not high. Providing the appropriate guide of the serum sampling time and the same guide in one patient and recommending the appropriate follow-up duration were necessary to ensure efficient TDM services. Also, full awareness of the vancomycin administration was needed to exclude errors in the reports. With the pharmacists’participation in the TDM services, these problems can be solved. By settling the guidelines of the vancomycin TDM services based on this study, we expect to improve the appropriacy and efficiency of vancomycin TDM services.
Abstract
Background : Vancomycin is a commonly administered antibiotic for hemodialysis patients. However, the best dosing and monitoring algorithms for these patients remain unclear thus far. The purpose of this study is to analyze and improve therapeutic drug monitoring (TDM) services for vancomycin in hemodialysis patients. Methods : Hemodialysis patients with TDM services between January 2015 and June 2016 were included. Sixty four cases of TDM services in 30 patients were retrospectively reviewed. Results : Appropriacy Among the 61(95%) reports recommending serum sampling time, 33(52%) cases followed the recommended sampling time for both peak and trough concentration. There were 12 errors across the 10 reports; all of them were a result of poor awareness of the administration of vancomycin. When additional TDM was followed, the time taken to the 2nd TDM (follow-up TDM) was between 4 and 30 days. Efficiency A total of 37(58%) cases followed the recommended dosing regimen and the total that did not follow were 20(31%). In the remaining cases(7 cases, 11%), the vancomycin administration was ceased after prior TDM. Among the 37(58%) cases, following the recommended dosing regimen, 9(24%) reports were expected to achieve the target trough level. Among the 20(31%) cases that did not follow the recommended dosing regimens, none of the reports achieved the target trough level. Conclusion : In our institutions’TDM services, TDM reports’appropriacy is unsatisfactory because the sampling wasn’t taken at the recommended times. The awareness of the vancomycin administration was poor and the 2nd TDM was delayed. Also, the TDM reports’efficiency were not high. Providing the appropriate guide of the serum sampling time and the same guide in one patient and recommending the appropriate follow-up duration were necessary to ensure efficient TDM services. Also, full awareness of the vancomycin administration was needed to exclude errors in the reports. With the pharmacists’participation in the TDM services, these problems can be solved. By settling the guidelines of the vancomycin TDM services based on this study, we expect to improve the appropriacy and efficiency of vancomycin TDM services.
참고문헌 (14)
- 김해숙, "Vancomycin Therapeutic Drug Monitoring 운영 실태 조사와 업무 개선 방안", 한국임상약학회지, 19(2), pp.120~130 (2009), 한국임상약학회
- Tobin CM, "Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire", J Antimicrob Chemother, 50(5), pp.713~718 (2002)
- Rybak M, "Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists", American Journal of Health-System Pharmacy, 66(1), pp.82~98 (2009)
- Brown M, "Weight-based loading of vancomycin in patients on hemodialysis", Clin Infect Dis, 53(2), pp.164~166 (2011)
- Zelenitsky SA, "Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis", Clin Infect Dis, 55(4), pp.527~533 (2012)
- Pai AB, "Vancomycin dosing in high flux hemodialysis : a limited-sampling algorithm", Am J Health Syst Pharm, 61(17), pp.1812~1816 (2004)
- Ariano RE, "Adequacy of a vancomycin dosing regimen in patients receiving highflux hemodialysis", Am J Kidney Dis, 46(4), pp.681~687 (2005)
- Barth RH, "Use of vancomycin in high-flux hemodialysis : experience with 130 courses of therapy", Kidney Int, 50(3), pp.929~936 (1996)
- Taylor ME, "Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance : a singlecenter experience", Am J Kidney Dis, 55(6), pp.1163~1165 (2010)
- Panais R, "A protocolized approach to vancomycin dosing in conventional hemodialysis", J Nephrol, 23(5), pp.569~574 (2010)
- Vandecasteele SJ, "Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg", mL in persons undergoing hemodialysis, 2011, pp.53(2), 124~129
- Crew P, "Vancomycin dosing and monitoring for patients with end-stage renal disease receiving intermittent hemodialysis", Am J Health Syst Pharm, 72(21), pp.1856~1864 (2015)
- Quale JM, "Removal of vancomycin by highflux hemodialysis membranes", Antimicrob Agents Chemother, 36(7), pp.1424~1426 (1992)
- Hirano R, "Pharmacistmanaged dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillinresistant Staphylococcus aureus infections : a single institution experience", Infect Drug Resist, 9, pp.243~252 (2016)